-
Event
09 December 2021, Virtual
The European Cancer Organisation is pleased to invite you to attend a virtual meeting on Cancer Cardiovascular Co-morbidities and Complications on Thursday 9 December 11:15-13:00 CET.
A unique collaboration of the MEP Heart Group and the Challenge Cancer Intergroup, the event will hear from patients, healthcare professionals, Members of the European Parliament and European Commissioner for Health and Food Safety Stella Kyriakides on the challenges, and ways forward, connected to the cardiovascular side effects of cancer treatment and the prevalence of cancer and cardiovascular related comorbidities.
Join the discussion by clicking on the "APPLY FOR REGISTRATION" button here below:
Read more
-
news
19 November 2021
2021 will be remembered for more than Covid-19. Stakeholders gathered at the European Cancer Summit this week also expressed optimism for the future based on the landmark publication of Europe’s Beating Cancer in February of this year.
Read more
-
news
18 November 2021
As part of the ‘Time To Act’ campaign, the European Cancer Organisation is launching its Data Navigator, making key data on the impact of Covid-19 on cancer available across European countries.
The European Cancer Organisation is pleased to announce the launch of the ‘Time To Act’ Data Navigator – a novel interactive visualisation tool presenting data on the impact of Covid-19 on cancer across an initial set of 17 European countries.
Read more
-
reports
November 2021
This morning, the European Cancer Organisation has published a fresh stakeholder consensus statement that expresses advice to the EU on how to ensure new recommendations to Member States on detecting cancer early, due to be published in 2022, can have the strongest impact.
Read more
-
news
17 November 2021
Human papillomavirus (HPV) vaccinations have achieved a huge reduction in cancer incidence. Recently-published research from the UK found that vaccination has almost eliminated cervical cancer in women in the vaccinated age groups.[1]
But it is the real-life experience of people who have suffered HPV-related cancers that provides the most compelling evidence for improving access to vaccination and screening services across Europe.
Read more
-
news
16 November 2021
This morning, the European Cancer Organisation has published a fresh stakeholder consensus statement that expresses advice to the EU on how to ensure new recommendations to Member States on detecting cancer early, due to be published in 2022, can have the strongest impact.
Read more
-
reports
November 2021
Ahead of the European Cancer Summit, the European Cancer Organisation has today published a new position paper, providing advice to the EU, WHO and national governments on how to harness the power of data and digital for better quality cancer care. The paper conveys consensus from healthcare professionals, patients, and the treatment and service development sector, and other invited experts.
Read more
-
news
15 November 2021
Ahead of the European Cancer Summit, the European Cancer Organisation has today published a new position paper, providing advice to the EU, WHO and national governments on how to harness the power of data and digital for better quality cancer care. The paper conveys consensus from healthcare professionals, patients, and the treatment and service development sector, and other invited experts.
Read more
-
news
27 October 2021
Non-small-cell lung cancer (NSCLC) accounts for 85 per cent of lung cancers, with 40 per cent of patients presenting at an advanced stage, including patients with metastatic disease.1
Read more
